Intrapulmonary pharmacokinetics and safety of eravacycline in critically ill patients with HAP/VAP caused by carbapenem-resistant Acinetobacter baumannii and Enterobacterales: a prospective study

发表于 2026-8-25 08:49:04

期刊：International Journal of Antimicrobial Agents

文献作者：Jingjing He; Nanyang Li; Xin Li; Yuancheng Chen; Jingjing Lin; Lei Yang; Jufang Wu; Xuehai Wu; Rui Li; Zhiping Liu; Yan Xu; Yangyi Dai; Wei Liu; Xu Zhu; Xiaofen Liu; Jin Hu; Gang Wu; Jing Zhang

出版日期：2026-8-

DOI号：10.1016/j.ijantimicag.2026.107960

下载链接：https://www.sciencedirect.com/sc ... 924857926002475/pdf

文献链接：https://doi.org/10.1016/j.ijantimicag.2026.107960

当前文献来源于 Elsevier BV。

备注信息：

发表于 2026-8-25 08:49:05

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Elsevier/Sciencedirect] Intrapulmonary pharmacokinetics and safety of eravacycline in critically ill patients with HAP/VAP caused by carbapenem-resistant Acinetobacter baumannii and Enterobacterales: a prospective study

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] Intrapulmonary pharmacokinetics and safety of eravacycline in critically ill patients with HAP/VAP caused by carbapenem-resistant Acinetobacter baumannii and Enterobacterales: a prospective study 一键复制